FDXF heads into its October 9 earnings with shorts rebuilding aggressively, analysts clustering well above the current price, and options traders leaning bullish — a three-way split that makes positioning unusually hard to read.
The short interest story has not changed since this morning's note: bears are still adding. Estimated short interest held near 5.4 million shares through the week, up roughly 25% over seven days and 28% over the past month. The build is steady across sessions, not a single-day spike. Borrow availability has tightened sharply — falling from around 1,550% a week ago to 700% now, a 59% move in seven days. At 700%, supply relative to shares borrowed remains comfortable, and the cost to borrow at 0.42% annualised is low in absolute terms. But the speed of the tightening matters: a 3x jump in weekly CTB alongside a consistent short build points to demand for borrows outpacing passive supply growth. If the build rate holds into earnings, the lending picture will need watching.
Options traders are reading the situation differently. The put/call ratio has fallen to 0.72 — more than two standard deviations below its 20-day average of 0.80. That is the most call-skewed reading relative to recent norms in months, and it cuts directly against the short-side conviction. The stock is down 6.3% on the week and 13.3% over the past month to $119, so the bullish options tilt is not chasing momentum — it looks more like a bet on mean reversion or a positive earnings catalyst.
The analyst community is similarly constructive. Coverage on FDXF has been building since the spin-off, and the picture from recent initiations is broadly positive. JP Morgan started at Overweight with a $160 target on September 8. Bernstein initiated at Market Perform with a $133 target two days later — the most cautious recent voice. Goldman Sachs, Jefferies, Citizens, and Raymond James all launched with Buy or Outperform ratings and targets ranging from $180 to $200. The consensus mean price target is $162.93, implying roughly 37% upside from the current $119. The PE has compressed to around 23x on a 30-day basis, while EV/EBITDA has eased to roughly 14.2x — both moving in the direction of value rather than growth premium, which may partly explain the analyst optimism.
Ownership is still dominated by the parent. FedEx Corporation holds 19.9% per its Schedule 13G filed in August, a passive stake that anchors the register. BlackRock disclosed 7% and Vanguard 5.5% in their own 13G filings from late July. No activist 13D is on file. All disclosed insider activity in the data is grant-type transactions — compensation awards rather than open-market conviction trades — so there is no clean insider signal to read either way.
The past two earnings prints offer a mixed reference point. The August result produced a modest 2.6% next-day gain before fading to a small loss over five days. The June print was rougher: a 4.1% drop on the day, extending to a 6% loss over the following week. October 9 is the next test, and the setup into it is the same tension that has defined the week — shorts building methodically while options and analysts point the other way.
See the live data behind this article on ORTEX.
Open FDXF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
